Doropharm Health s.r.o.

Active
IČO 55507557limited liability company (s.r.o.)Founded 2023Bratislava - mestská časť Nové Mesto

Key figures

70 465 680 €-5,0%
Revenue 2025
+304,2%
Average annual growth 2023–2025
020 m40 m60 m80 m202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 500 € (<1 % of distributable profit).

In addition, equity decreased by 439 500 € other than from retained earnings — e.g. a share capital reduction, a payout from other funds or a revaluation. The open data does not show whether this was a payout to shareholders.

History
dividends other decrease in equity
2025500 €+439 500 € other
20240 €

Summary: Doropharm Health s.r.o.

What kind of company is it?

Doropharm Health s.r.o. (IČO 55507557) is a limited liability company (s.r.o.). The company was incorporated in 2023 and has existed for 3 years. Registered office according to the register: Bratislava - mestská časť Nové Mesto. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 20–24 employees.

Who runs the company and who owns it?

The statutory body has 2 members. According to the register, the company has one shareholder. The registered capital is 5 000 €.

How is the company doing financially?

Revenue for 2025 was 70 465 680 €, down 5,0 % on the previous year (74 187 309 €). From 2023 to 2025, revenue grew by an average of 304 % per year. Net profit for 2025 was 433 645 € (0,6 % of revenue). The company was profitable in 2 of the 3 reported years. Personnel costs for 2025 were 727 886 €. At the end of 2025 the company had total assets of 12 538 463 € and equity of 3 396 392 € (equity ratio 27,1 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2023–2025
202320242025
Revenue (net turnover)4 313 04174 187 30970 465 680
Profit for the reporting year-31 747345 494433 645
Retained earnings of previous periods0-31 747313 247
Total assets12 528 10213 810 97012 538 463
Total liabilities9 470 84910 408 2239 142 071
Total equity3 057 2533 402 7473 396 392
Calculated dividends—0500

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
100 %directordirectorDoropharm Health s.r.o.Doropharm Health s.r.o.SPLIPHARMArzneiwaren Handelsg…SPLIPHARM Arzneiwaren HandelsgmbHJGJulian Etienne GosseJulian Etienne GosseCSMag.pharm. ChristophAndreas SplichalMag.pharm. Christoph Andreas Splichal
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements11

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Doropharm Health s.r.o. (IČO 55507557) – revenue 70,5M €